The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2019 | Transplantation in the era of CAR T-cell therapy
Julio Delgado
• 5 Apr 2019
Here, Julio Delgado, MD, PhD, from the Clinical and Provincial Hospital of Barcelona, Barcelona, Spain, debates the need for transplantation in the era of CAR T-cell therapy. Dr Delgado was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.
